🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/11/1977 | 1,51 | 1,52 | 1,51 | 1,51 | +0,44% | 1,10% | 2.542.867 |
| 15/11/1977 | 1,49 | 1,50 | 1,49 | 1,50 | +0,67% | 1,11% | 3.493.613 |
| 14/11/1977 | 1,49 | 1,51 | 1,48 | 1,49 | +0,22% | 1,56% | 1.543.075 |
| 11/11/1977 | 1,47 | 1,49 | 1,47 | 1,49 | +3,69% | 1,81% | 2.527.776 |
| 10/11/1977 | 1,42 | 1,45 | 1,42 | 1,44 | +1,64% | 1,63% | 3.882.211 |
| 09/11/1977 | 1,41 | 1,42 | 1,40 | 1,41 | +0,47% | 1,17% | 1.942.992 |
| 08/11/1977 | 1,41 | 1,41 | 1,39 | 1,41 | -0,23% | 1,41% | 2.014.675 |
| 07/11/1977 | 1,40 | 1,41 | 1,40 | 1,41 | +0,71% | 0,94% | 2.742.826 |
| 04/11/1977 | 1,39 | 1,41 | 1,38 | 1,40 | +0,96% | 1,91% | 3.550.205 |
| 03/11/1977 | 1,41 | 1,43 | 1,39 | 1,39 | -1,41% | 3,06% | 1.995.811 |
| 02/11/1977 | 1,40 | 1,41 | 1,39 | 1,41 | +0,71% | 1,90% | 2.033.539 |
| 01/11/1977 | 1,43 | 1,44 | 1,40 | 1,40 | -2,31% | 3,00% | 1.527.984 |
| 31/10/1977 | 1,46 | 1,46 | 1,43 | 1,43 | -1,82% | 1,82% | 1.143.158 |
| 28/10/1977 | 1,44 | 1,46 | 1,44 | 1,46 | +1,38% | 1,15% | 1.490.256 |
| 27/10/1977 | 1,43 | 1,46 | 1,43 | 1,44 | +1,16% | 1,85% | 4.361.357 |
| 26/10/1977 | 1,40 | 1,44 | 1,39 | 1,42 | +1,66% | 3,32% | 3.965.213 |
| 25/10/1977 | 1,36 | 1,40 | 1,36 | 1,40 | +2,68% | 3,17% | 3.429.475 |
| 24/10/1977 | 1,37 | 1,37 | 1,35 | 1,36 | -0,48% | 1,21% | 2.233.498 |
| 21/10/1977 | 1,38 | 1,38 | 1,36 | 1,37 | -0,73% | 1,44% | 2.203.315 |
| 20/10/1977 | 1,38 | 1,40 | 1,37 | 1,38 | -0,48% | 2,16% | 2.754.144 |
| 19/10/1977 | 1,43 | 1,43 | 1,36 | 1,38 | -3,69% | 4,87% | 4.606.589 |
| 18/10/1977 | 1,47 | 1,47 | 1,40 | 1,44 | -2,03% | 4,74% | 2.195.770 |
| 17/10/1977 | 1,48 | 1,49 | 1,46 | 1,47 | -1,12% | 1,79% | 1.233.706 |
| 14/10/1977 | 1,49 | 1,49 | 1,46 | 1,48 | -0,44% | 1,56% | 1.414.800 |
| 13/10/1977 | 1,52 | 1,53 | 1,48 | 1,49 | -1,97% | 3,70% | 4.395.312 |
| 12/10/1977 | 1,54 | 1,54 | 1,51 | 1,52 | -1,07% | 1,72% | 2.108.995 |
| 11/10/1977 | 1,54 | 1,55 | 1,54 | 1,54 | -0,21% | 1,08% | 1.169.568 |
| 10/10/1977 | 1,54 | 1,55 | 1,54 | 1,54 | +0,00% | 0,86% | 814.925 |
| 07/10/1977 | 1,54 | 1,56 | 1,54 | 1,54 | -0,21% | 1,08% | 1.346.890 |
| 06/10/1977 | 1,54 | 1,56 | 1,54 | 1,54 | +0,00% | 1,50% | 1.135.613 |